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TheRIG-I-like receptors (RLRs) signal innate immune
defenses upon RNA virus infection, but their roles in
adaptive immunity have not been clearly defined.
Here, we showed that the RLR LGP2 was not essen-
tial for induction of innate immune defenses, but
rather was required for controlling antigen-specific
CD8+ T cell survival and fitness during peripheral
T cell-number expansion in response to virus in-
fection. Adoptive transfer and biochemical studies
demonstrated that T cell-receptor signaling induced
LGP2 expression wherein LGP2 operated to regulate
death-receptor signaling and imparted sensitivity to
CD95-mediated cell death. Thus, LGP2 promotes
an essential prosurvival signal in response to antigen
stimulation to confer CD8+ T cell-number expan-
sion and effector functions against divergent RNA
viruses, including West Nile virus and lymphocytic
choriomeningitis virus.
INTRODUCTION
Pathogen recognition and signaling of cell-intrinsic innate immu-
nity is a crucial process for initiation of the immune response to
virus infection. Early recognition of RNA viruses and the induc-
tion of innate antiviral immunity are largely dependent on the
RIG-I-like receptors (RLRs) (Loo et al., 2008). Members of the
RLR family of cytosolic RNA helicases, which includes RIG-I,
MDA5, and LGP2, are expressed basally at low levels in most
tissues and are induced by type I interferon (IFN). RIG-I and
MDA5 encode amino-terminal tandem caspase activation and
recruitment domains (CARDs) that function in downstream
signaling to induce the expression of IFN and other proinflamma-
tory cytokines; in contrast, LGP2 (encoded by Dhx58) neither
possesses CARDs nor has an analogous signaling effector
domain (Yoneyama et al., 2005). Upon binding to RNA path-
ogen-associated molecular patterns, the RLRs undergo confor-
mational changes and modifications that promote their signalingfunctions. In particular, RIG-I and MDA5 signal downstream
through direct interactions with the MAVS (also known as
IPS-1) adaptor protein mediated by CARD-CARD interaction to
initiate signaling of the activation of transcription factors IRF-3
and NF-kB. This process induces expression of immune effector
genes, IFN, and IFN-stimulated genes (ISGs) that impart innate
and adaptive immune defenses to limit virus replication and
spread (Wilkins and Gale, 2010). In contrast, LGP2 can function
as a negative regulator of RLR signaling by binding viral double-
stranded RNA (Rothenfusser et al., 2005), inhibiting RIG-I multi-
merization (Saito et al., 2007), or competing for a common dock-
ing site with IKK-ε onMAVS to suppress innate immune signaling
actions (Komuro and Horvath, 2006). More recent studies with
Dhx58/ mice have suggested that LGP2 can also function as
a positive cofactor of RLR signaling of innate immune defenses
(Satoh et al., 2010; Venkataraman et al., 2007), although the
exact mechanism by which LGP2 contributes to RIG-I or
MDA5 signaling actions remains unknown.
West Nile virus (WNV) is an emerging flavivirus of public health
importance and is now a major cause of epidemic encephalitis
worldwide (Centers for Disease Control and Prevention (CDC),
2008). RLR signaling and adaptive immune responses are
essential for immune protection against WNV infection. Within
infected cells, WNV is recognized as a pathogen by the com-
bined actions of RIG-I and MDA5 to temporally induce innate
immune responses that are essential in controlling virus replica-
tion and modulating B and T cell responses (Fredericksen et al.,
2008; Suthar et al., 2010). Whereas humoral immune responses
are important for controlling systemic virus infection (Diamond
et al., 2003a; Diamond et al., 2003b), cell-mediated responses,
specifically those of CD8+ T cells (Brien et al., 2011; Shrestha
and Diamond, 2004; Shrestha et al., 2006; Szretter et al.,
2010), are critical in controlling virus replication and virus-
induced pathology within the CNS. CD4+ T cells play a more
prominent role in providing help in development of virus-specific
antibody responses and in clearance of WNV from the CNS at
later times during infection (Sitati and Diamond, 2006). Regula-
tion of the adaptive immune response is dependent on RLR
signaling through MAVS (Suthar et al., 2010). RLR signaling
also modulates the quality and balance of the adaptive immune
response, including governance of T cell-number expansion,Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc. 235
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neutralizing antibodies (Suthar et al., 2010). These observations
indicate that RIG-I and MDA5 signaling through MAVS is impor-
tant for an effective adaptive immune response against virus
infection; however, the role of LGP2 in antiviral immunity and
pathogenesis ofWNV infection has remained poorly understood.
In this study, we generated a Dhx58/ mouse line on a pure
C57BL/6 background and evaluated the role of LGP2 in RNA
virus infection and immunity. Our results revealed an essential
role for LGP2 in promoting CD8+ T cell survival and fitness
through regulation of sensitivity to death-receptor-mediated
cell death. We also confirmed a role for LGP2 function as a posi-
tive regulator of RLR signaling of innate immune defenses in
primary fibroblasts and myeloid-derived cells ex vivo, and we
demonstrated that LGP2 is not essential for induction of innate
immunity in lymphoid organs and within the CNS in response
to WNV challenge. Importantly, our study defines a cell-intrinsic
role for LGP2 in regulation of T cell responses during RNA
virus infection and further demonstrates the importance of RLR
signaling in regulating immunity and infection.
RESULTS
LGP2 Is Not Required for Innate Defenses but Serves
to Enhance RLR-Dependent IFN Induction
To define the role of LGP2 in directing immunity to virus infec-
tion, we generated a line of Dhx58/ mice on a pure C57BL/6
background (Figure 1A), thus alleviating confounding variables
from mixed genetic background present in existing Dhx58/
mouse lines (Satoh et al., 2010; Venkataraman et al., 2007).
We engineered a gene-targeting vector that uniquely replaced
Dhx58 exons 2 to 8, including the translation start codon, with
a neomycin cassette. This construct was used to target Dhx58
in C57BL/6 embryonic stem cells, which were injected into
a C57BL/6 donor mouse embryo. Southern blot analysis and
quantitative RT-PCR (qRT-PCR) confirmed the deletion of
LGP2 (Figure 1B and data not shown, respectively). Progeny
mice from Dhx58+/ or Dhx58/ intercrosses were born at a
normal Mendelian ratio and showed no overt physical defects,
in contrast to another Dhx58/ mouse line (Satoh et al., 2010).
Expression of LGP2 was not detected in Dhx58/-derived
mouse embryo fibroblasts (MEFs) cultured in the presence of
IFN (Figure 1C). When infected with Sendai virus (SeV), Dengue
virus type 2 (DENV2), or WNV (WNV-TX-02; representing the
pathogenic and emerging strain of WNV [Keller et al., 2006]),
Dhx58/ MEFs produced slightly reduced amounts of IFN-b
but retained temporal induction of IFIT2 and IFIT3 expression
(Figure 1D). IFN-b induction by SeV, DENV2, and WNV is depen-
dent on RLR signaling (Loo et al., 2008), and IFIT2 and IFIT3
are ISGs whose expression can be driven acutely by IRF-3
alone (Grandvaux et al., 2002). These results indicate that
virus-induced RLR signaling to IRF-3 remains intact but IFN-b
induction is moderately attenuated in MEFs in the absence
of LGP2.
To determine the role of LGP2 in triggering innate immune
defenses in myeloid cells, we evaluated the response of bone-
marrow-derived dendritic cells (DCs) and macrophages to
WNV infection. Both cell types are targets of WNV infection
in vivo (Samuel and Diamond, 2006). Dhx58/ DCs (Figure 1E)236 Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc.and macrophages (Figure 1F) infected with WNV produced
reduced amounts of IFN-b compared to wild-type (WT) cells,
suggesting a positive regulatory role for LGP2 in facilitating
IFN-b production in myeloid cells. In contrast, LGP2 was highly
expressed in WT WNV-infected DCs (Figure 1G) and macro-
phages (Figure 1H), whereas the absence of LGP2 did not alter
the expression kinetics or the magnitude of IRF-3 target genes
or ISGs, including those that encode RIG-I, MDA5, STAT-1,
IFIT2, and IFIT3. We observed significantly higher virus replica-
tion at 24 hr postinfection in WNV-infected Dhx58/ DCs (Fig-
ure 1I) and macrophages (Figure 1J) compared to WT infected
cells. However, by later time points, WT and Dhx58/ infected
cells produced similar amounts of infectious virus. Taken
together, these results validate LGP2 as a nonessential but posi-
tive regulator of RLR signaling of innate immune defenses and
demonstrate that it can function to enhance IFN-b production
during acute RNA virus infection.
LGP2 Is Essential for Protection against WNV Infection
and Virus Control in the CNS
To examine the role of LGP2 in mediating protection against
virus infection in vivo, we challenged WT and Dhx58/ mice
with WNV (WNV-TX) and assessed clinical phenotype, virologic
as well as immunologic responses. Following a subcutaneous
inoculation in the footpad, WNV replicates in the popliteal drain-
ing lymph node (pDLN), which results in viremia and spread to
the spleen and CNS tissues (e.g., brain and spinal cord), thus
recapitulating the pathogenesis of human infection (Samuel
and Diamond, 2006). Dhx58/ mice were found to be more
susceptible to WNV infection (Figure 2A) and exhibited a signifi-
cant increase in mortality (87.5% compared to 13% in WT mice;
p < 0.0001) as compared to WT infected mice. Thus, LGP2 is
required for protection against WNV infection in vivo.
To begin to define the basis for the increased mortality in
Dhx58/mice, we evaluated the viral burden in different tissues
over time. Analysis of virus levels within the pDLN (Figure 2B) and
spleen (Figure 2C) revealed no differences in tissue viral load
betweenWT andDhx58/ infectedmice. In contrast toMavs/
mice (Suthar et al., 2010), Dhx58/ infected mice exhibited
normal tissue tropism, with no expansion to organs (e.g., the
kidney) that normally are resistant to infection in WT mice. (Fig-
ure 2D). Furthermore, comparable peripheral innate immune
responses were observed in the absence of LGP2, as evidenced
by similar amounts of IFN-b production (Figure 2E) and ISG
expression in the pDLN (Figure 2F-G), ISG expression in the
spleen (Figure 2H), and type I IFN in the serum (Figure 2I).
Dhx58/ infected mice displayed similar kinetics of viral
neuroinvasion to those of WT infected mice (see day 6, Fig-
ure 3A), although significantly higher viral loads were observed
in the brain at late time points during infection, indicating that
LGP2 is required for controlling virus replication and/or spread
after entering the CNS. Accordingly, we examined WNV replica-
tion and innate immune defenses in primary cortical neurons
isolated from WT or Dhx58/ mice after ex vivo infection. We
found that LGP2 was not essential for controlling virus replica-
tion in neurons, as WNV reached end-point viral loads in
Dhx58/ cortical neurons similar to those of WT neurons (Fig-
ure 3B). Furthermore, LGP2 was not required for the induction
or enhancement of innate immune defenses against infection
Figure 1. LGP2 Is a Positive Regulator of RLR Signaling in Primary Fibroblasts and Myeloid-Derived Cells
(A) LGP2 gene-targeting strategy and predicted gene disruption.
(B) Southern blot analysis of Dhx58+/+ and Dhx58+/ mice (WT allele = 5.7 kb; Dhx58/ allele = 3.7 kb).
(C) Immunoblot analysis of MEFs from C57BL/6 (WT) and Dhx58/ mice treated with type I IFN for 24 hr.
(D) WT and Dhx58/ MEFs were mock-infected (M) or infected with Sendai virus (200 hemagluttinin units/ml; left panel), DENV-2 (moi 1.0; middle panel), and
WNV-TX (moi 1.0; right panel). IFN-b in the supernatant was measured by ELISA (upper) and ISG expression assessed by immunoblotting (lower) at the indicated
hr postinfection.
(E–J) Primary bone-marrow-derived DCs and macrophages recovered fromWT and Dhx58/mice were mock infected or infected with WNV-TX at an moi of 1.
Cells and culture media were harvested at the times indicated for determination of IFN-b production (E, DCs; F, macrophages), ISG expression (G, DCs; =, H,
macrophages), and virus load (I, DCs; J, macrophages).
Dotted lines represent the limit of assay sensitivity. Graphs show the mean ± SD from triplicate samples and representative of three independent experiments.
Asterisks denote p < 0.05.
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Figure 2. LGP2 Is Required for Protection against WNV Infection
(A) Survival of WT (n = 26) and Dhx58/ (n = 17) adult mice infected s.c. with 100 PFU of WNV-TX.
(B–D) Viral-burden analysis from WT and Dhx58/ infected mice in the (B) pDLN, (C) spleen, and (D) kidney (Mavs/ mice also analyzed).
(E–G) IFN-b (E), IFIT1(F), and IFIT2 expression (G) in the pDLN were determined by qRT-PCR.
(H) Immunoblot analysis of spleens from WT and Dhx58/ mock-infected (M) and WNV-TX-infected mice at the indicated days postinfection.
(I) Serum type I IFN measured by an L929 bioassay.
Dotted lines represent the limit of assay sensitivity. Graphs show the mean ± SD of triplicate biological samples from three independent experiments.
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expression (Figure 3D) were similar between WT and Dhx58/
infected neurons. Although we detected an elevated basal level
of STAT1 in Dhx58/ cortical neurons, IFN treatment induced
ISG expression similarly between WT and Dhx58/ cells. IFN
treatment also induced RLR expression, revealing that RLRs
are inducible in neuronal cells. Overall, these results demon-
strate that, in neurons, LGP2 does not contribute significantly
to regulation of innate immune responses or controlling virus
replication.
CNS Inflammation in Dhx58–/– Mice during WNV
Infection
Because of the absence of a direct effect on viral burden in
neurons, we hypothesized that LGP2 might protect against
WNV infection in the brain by modulating cell-extrinsic immune
control mechanisms. Therefore, we assessed the extent of
inflammation and pathology in the brains of WT and Dhx58/
mice after WNV infection. Histological analysis of brain sec-
tions recovered from WT mice 8 days after infection revealed
moderate inflammation and sparse neuronal damage, consistent
with previously published studies (Figure 3E; Suthar et al., 2010).238 Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc.In addition, mononuclear cell infiltrates were present in the
hippocampus and cerebral cortex regions, implying the onset
of the inflammatory response that mediates protective immunity
to infection. In contrast, brains from Dhx58/ infected mice
displayed extensive damage to neurons in the hippocampus
and cortex regions, including pyknotic and vacuolated neurons.
Surprisingly, we observed little to no inflammation within the
hippocampus and cortex of brains from infected Dhx58/
mice, despite the near 3-log increase in brain viral load compared
to WT mice. Furthermore, the number of total lymphocytes iso-
lated from the brain of infected Dhx58/ mice was significantly
reduced (70% reduction) as compared to WT mice (Figure 3F).
Although the brains of infected Dhx58/ mice did not exhibit
a significant decrease in the numbers of CD4+ T cells (Figure 3G),
there were significantly reduced numbers of total CD8+ T cells
(55% reduction; Figure 3H) and antigen-specific CD8+ T cells
(62% reduction; Figures 3I and 3J). These results indicate that
LGP2 regulates CD8+ T cell recruitment to the CNS.
LGP2 Regulates CD8+ T Cell Accumulation
To define whether the defects in inflammation were specific to
the CNS or indicative of a more global inflammatory control
Figure 3. LGP2 Is Required for Regulating CNS Inflammation and Pathology
(A) Viral burden in the brains of infected mice was determined at the indicated days postinfection. The dotted line represents the limit of assay sensitivity.
(B–D) Primary cortical neurons were generated fromWT and Dhx58/ mice and infected at an moi of 1, and cell supernatants were collected at the indicated hr
postinfection.
(B) Viral titers in the supernatants were determined by plaque assay.
(C) Type I IFN in the supernatants was measured by a bioassay.
(D) Immunoblot analysis from cell lysates of mock (M), WNV-TX-infected, and type I IFN-treated cortical neurons.
(E) H&E-stained sagittal-brain-tissue sections. Arrows denote areas of inflammation and pathology.
(F–J) Brain leukocytes were recovered fromWT andDhx58/mice eight days postinfection. M, Mock; W,WNV-TX. Graphs show themean ± SD (n = 3). Data are
representative of two or more independent experiments. Asterisks denote p < 0.05.
(F) Total cells of brain lymphocytes were determined after cell counting.
(G) Total CD4+ T cells.
(H) Total CD8+ T cells.
(I) Representative flow analysis and gating schematic for identifying NS4b tetramer-specific CD8+ T cells.
(J) Total NS4b tetramer-specific CD8+ T cells.
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within the spleens of WNV-infected mice. Spleens recovered
from Dhx58/ mice between 4 and 6 days postinfection ex-hibited similar increases in total lymphocytes to those of spleens
fromWT infected mice (Figure 4A). However, by day 7 postinfec-
tion, spleens from Dhx58/ mice contained significantly lowerImmunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc. 239
Figure 4. LGP2 Regulates CD8+ T Cell Survival and Fitness
WT and Dhx58/mice were mock infected (M) or infected with WNV-TX. Spleens were harvested, and immune cells were isolated, counted, and characterized
by flow cytometry. Graphs show the mean ± SD from triplicate samples from two or more experiments. Asterisks denote p < 0.05.
(A) Total cells (splenocytes).
(B) Total number of CD8+ T cells.
(C) Total number of NS4b tetramer-specific CD8+ T cells.
(D) BrdU incorporation on cells gated on NS4b tetramer-specific CD8+ T cells from day 6 postinfection (left panel, representative histogram; right panel, bar
graph).
(E) Annexin V+ (left panel) and CD44 (right panel) staining on NS4b tetramer-specific CD8+ T cells (representative histogram from day 10 postinfection).
(F) Bar graph of Annexin V+ cells.
(G) Flow-cytometry histogram of TNF-a- and IFN-g-secreting CD8+ T cells upon restimulation with media (left panel) or NS4b peptide (right panel) on day 10
postinfection.
(H–J) Frequency and total number of (H) IFN-g-, (I) TNF-a-, and (J) IFN-g- and TNF-a-secreting CD8+ T cells (top panels, frequency; bottom panels, total cells).
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Figure 5. Type I IFN and TCR Conjugation Stimulate Expression of
LGP2 and RIG-I in CD8+ T Cells
CD8+ T cells were purified from WT mice through negative selection and
stimulated with plate-bound anti-CD3 and anti-CD28. Parallel cultures were
treated with IFN-b (100 IU/ml) for 24 hr. Cell lysates were collected and
immunoblot analysis was performed using the indicated antibodies. Data are
representative of three independent experiments.
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fected mice, and this trend continued through day 10 postinfec-
tion. We observed similar trends in the number of total CD8+
T cells (Figure 4B) and antigen-specific CD8+ T cells (Figure 4C).
Interestingly, and in contrast to mice deficient in RLR signaling
(i.e., Mavs/ mice; Suthar et al., 2010), we did not observe
differences in either the quantity or the quality of the WNV-
specific humoral response (Table S1 available online), suggest-
ing that LGP2 does not directly govern B cell development or
CD4+ T cell help during WNV infection (Sitati and Diamond,
2006). Thus, LGP2 modulates CD8+ T cell responses, but not
humoral immune responses, against WNV infection.
LGP2 Is Required for CD8+ T Cell Fitness and Survival
To define the mechanisms by which LGP2 regulates CD8+
T cells, we evaluated T cell priming, activation, and expansion
in response to virus infection. Ex vivo assessment of bone-
marrow-derived DCs and macrophages revealed that the
kinetics of maturation of these antigen-presenting cells, as mea-
sured by expression of key costimulatory molecules (CD80,
CD86, and CD40) and major histocompatibility complex (MHC)
classes I and II, were unaltered in the absence of LGP2 (data
not shown). Furthermore, in vivo analysis of splenic DCs and
macrophages revealed no differences in the expansion or matu-
ration status of each during WNV infection (data not shown),
demonstrating that LGP2 does not regulate DC or macrophage
maturation. As RLR signaling has been shown to control regula-
tory T cell expansion during WNV infection (Suthar et al., 2010),
we examined this population of cells in WT and Dhx58/ in-
fected mice. In the absence of LGP2, there was no change in
regulatory T cell expansion compared to WT infected mice (Fig-
ure S1), suggesting that the reduction in CD8+ T cells inDhx58/
infected mice was not due to aberrant expansion of regulatory
T cells during WNV infection.
Because CD8+ T cells are essential for protection against
acute WNV infection and the development of WNV encephalitis
(Shrestha and Diamond, 2004), and given the robustness of
CD8+ T cell responses during WNV infection (Brien et al., 2007,
2008), we assessed the mechanisms by which LGP2 governs
CD8+ T cell function. To determine whether LGP2 is required
for CD8+ T cell proliferation, WT and Dhx58/ WNV-infected
mice were pulsed with bromodeoxyuridine (BrdU) on day 6
postinfection, a time point that directly precedes the dramatic
decrease in CD8+ T cell numbers inDhx58/ infected mice (Fig-
ure 4D). Total CD8+ T cells (Figure S2A) and antigen-specific
CD8+ T cells from Dhx58/ infected mice showed similar levels
of BrdU incorporation to those of WT infected mice, indicating
that LGP2 does not regulate CD8+ T cell proliferation. We also
assessed a possible role of LGP2 in supporting CD8+ T cell
survival after antigen stimulation by analyzing the percentage
of CD8+ T cells undergoing apoptosis (as determined by Annexin
V+ staining) in WT and Dhx58/ infected mice. On day 6 postin-
fection, antigen-specific CD8+ T cells from WT and Dhx58/
infected mice showed low but similar frequency of apoptotic
cells (Figures 4E and 4F). By day 10 postinfection, antigen-
specific (NS4b tetramer+) CD8+ T cells from Dhx58/ infected
mice displayed a significant increase (2.7-fold) in apoptotic cell
frequency, suggesting that LGP2 regulates CD8+ T cell survival.
Similarly, after restimulation with the WNV immunodominantNS4b peptide (Brien et al., 2007; Purtha et al., 2007), splenocytes
from Dhx58/ infected mice had reduced frequency and
numbers of IFN-g (Figure 4H), tumor necrosis factor alpha
(TNF-a) (Figure 4I), and TNF-a- and IFN-g-secreting CD8+
T cells (Figure 4J) as compared to WT infected mice, with
maximumdifferences observed onday 10 postinfection. Further-
more, IL-2 expression, an important cytokine for regulating T cell
growth and function, was not observed in CD8+ T cells from WT
and Dhx58/ mice between days 6 and 10 postinfection (data
not shown). To determine whether the reduced numbers of
effector T cells in Dhx58/mice were specific to WNV infection,
we evaluated CD8+ T cell survival and fitness after challenge of
WT and Dhx58/ mice with another RNA virus, lymphocytic
choriomeningitis virus (LCMV)-Armstrong. Similar to that seen
after WNV infection, LCMV antigen-specific (GP33 tetramer+)
CD8+ T cells from infected Dhx58/ mice showed enhanced
apoptosis and reduced effector functions as compared to cells
from WT infected mice (Figures S2B and S2C). Together, these
results demonstrate that LGP2 participates in the regulation of
CD8+ T cell survival and fitness during the immune response to
RNA virus infection.
LGP2 Is Expressed in CD8+ T Cells and Regulates
Survival in a Cell-Intrinsic Manner
We next measured RLR expression and abundance in purified
CD8+ T cells recovered from WT mice. In general, CD8+ T cells
expressed a low basal level of each RLR, including LGP2, and
RLR abundance increased along with other ISGs when the cells
were treated with IFN-b (Figure 5). Stimulation of CD8+ T cells
with plate-bound anti-CD3 and anti-CD28 induced RLR expres-
sion, with LGP2 expression accumulating to the highest levels
among the RLRs (Figure 5). These findings demonstrate that
LGP2 expression in CD8+ T cells is induced by type I IFN and
TCR signaling, suggesting a cell-intrinsic role for LGP2 in regula-
tion of CD8+ T cell fitness during RNA virus infection.Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc. 241
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extrinsic manner to promote CD8+ T cell survival, we isolated
CD8+ T cells from CD45.1 congenic WT mice and Dhx58/
(CD45.2) mice and adoptively transferred them into Rag1/
mice at a 1:1 cell ratio. One day after transfer, recipient mice
were injected with diluent alone (uninfected control) or chal-
lenged with WNV (Figure 6A). Examination of donor cells in unin-
fected Rag1/ recipient mice showed comparable division of
carboxyfluorescein succinimidyl ester (CFSE)-labeled WT and
Dhx58/ CD8+ T cells (Figure 6B), with low Annexin V+ staining
apparent in either WT- or Dhx58/-derived CD8+ T cells (data
not shown). Thus, in the absence of infection, Dhx58/ CD8+
T cells do not show overt defects in homeostatic proliferation
or survival. However, the frequency and total numbers of
antigen-specific Dhx58/CD8+ T cells were reduced by day
8 post-WNV-infection (Figure 6C). To determine whether this
reduction was due to turnover of cells or an inability of cells
to effectively proliferate, we evaluated BrdU incorporation on
day 8 postinfection. Antigen-specific Dhx58/ CD8+ T cells dis-
played enhanced proliferation as compared to WT CD8+ T cells
(Figure 6D), demonstrating that dysregulated cell proliferation
does not account for the reduction in CD8+ T cells. Another
possible explanation for the reduction in CD8+ T cells is dys-
regulated development of short-lived effector cell (SLEC) and
memory-precursor effector cell (MPEC) populations in the ab-
sence of LGP2 (Joshi et al., 2007). Antigen-specific Dhx58/
CD8+ T cells displayed comparable percentages of KLRG1-ex-
pressing cells, a marker for discriminating SLECs, and IL-7Ra
(CD127)-expressing cells, a marker for discriminating MPECs
(Figure S3). This suggests that LGP2 is not required for program-
ming development of SLEC or MPEC populations during WNV
infection. Consistent with our previous observations, antigen-
specific Dhx58/CD8+ T cells displayed increased Annexin V+
staining compared to WT CD8+ T cells (Figure 6E). Furthermore,
when restimulated with the immunodominant NS4b peptide
ex vivo (Figure 6F), CD8+ T cells from Dhx58/ mice exhibited
compromised effector functions compared to WT cells, includ-
ing a reduction in single-positive IFN-g- (41.5% reduction; p =
0.001), TNF-a- (40.5% reduction; p = 0.004), and double-positive
TNFa- and IFN-g-secreting cells (43.9% reduction; p = 0.004).
LGP2 has been reported to bind to MAVS to regulate RLR
signaling (Komuro and Horvath, 2006). Therefore, we assessed
the role of MAVS in regulating CD8+ T cell survival using the
adoptive transfer model. We observed no enhancement of cell
death in Mavs/ CD8+ T cells (data not shown), consistent
with our previous studies (Suthar et al., 2010). Taken together,
these results demonstrate that LGP2 functions in a cell-intrinsic
manner to promote CD8+ cell survival and function after antigen
stimulation, independently of MAVS.
LGP2 Imparts Sensitivity to CD95-Mediated Cell Death
Cell death in T cells can occur through activation of the intrin-
sic apoptosis pathway, involving Bcl-2, Bim, and Bcl-xL, or
through the extrinsic pathway, initiated by death-receptor sig-
naling (Tourneur and Chiocchia, 2010). Using the adoptive trans-
fer model, we evaluated key components in the intrinsic and
extrinsic apoptosis signaling pathways to identify the mecha-
nism by which LGP2 operates to control CD8+ T cell survival.
In the absence of LGP2, antiapoptotic factors, including Bcl-2242 Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc.and Bcl-xL, and the proapoptotic factor Bim displayed expres-
sion in antigen-specific CD8+ T cells similar to that of WT CD8+
T cells, suggesting that LGP2 does not regulate the intrinsic
apoptosis signaling pathway through altered expression of these
factors (Figure S4). In contrast, antigen-specific Dhx58/ CD8+
T cells displayed enhanced caspase-8 (Figure 7A) and caspase-
3 and -7 activity (Figure 7B), suggesting that LGP2 regulates
the extrinsic apoptosis signaling pathway. Members of the
TNF superfamily are important for regulation of the extrinsic
apoptosis pathway in T cells. For example, ligation of TNFa,
TNF-related apoptosis-inducing ligand (TRAIL), and CD95 ligand
(CD95L) to their cognate receptors (TNF-RI and -RII, TRAIL-R2,
and CD95, respectively) leads to formation of the death-inducing
signaling complex followed by activation of caspase-8, activa-
tion of caspase-3 and caspase-7, and ultimately cell death (Ag-
garwal, 2003). In the absence of LGP2, antigen-specific CD8+
T cells displayed enhanced expression of TNF-RI (Figure 7C),
TNF-RII (Figure 7D), TRAIL-R2 (Figure 7E), and CD95 (Fig-
ure 7F) compared to WT CD8+ T cells during virus infection. To
determine whether the enhanced receptor expression correlated
with increased sensitivity to cell death, splenocytes were treated
exogenously with TNF-a, TRAIL, or CD95L, and cell death was
evaluated in antigen-specific CD8+ T cells. Consistent with
ex vivo examination (Figure 6E), antigen-specific CD8+ T cells
from Dhx58/ mice displayed enhanced Annexin V+ staining
as compared toWT cells in the absence of exogenous treatment,
further demonstrating an overall increased sensitivity for cell
death in the absence of LGP2 (Figures 7G–7I). WT or Dhx58/
antigen-specific CD8+ T cells displayed no enhancement of
cell death upon treatment with TNF-a (Figure 7G), whereas treat-
ment with TRAIL led to similar increases in cell death between
WT and Dhx58/ antigen-specific CD8+ T cells (Figure 7H). In
contrast, treatment with CD95L led to an increase in cell death
of antigen-specific CD8+ T cells from Dhx58/, but not WT
mice (Figure 7I). In fact, CD95L-treated Dhx58/ CD8+ T cells
displayed an increase in cell death from 21% to 32.5% upon
ex vivo treatment as compared to WT CD8+ T cells (7.8%
Annexin V+ cells in treated and untreated conditions). Although
we did not observe a similar enhancement of sensitivity over
WT CD8+ T cells upon TNF-a or TRAIL treatment, we cannot
preclude the possibility that signaling through these pathways
or other death receptors within the TNF superfamily contributes
to the enhanced death of antigen-specificDhx58/CD8+ T cells
during virus infection. Taken together, these findings demon-
strate a role for LGP2 in promoting CD8+ T cell survival through
regulation of sensitivity to death-receptor-mediated signaling of
cell death.
DISCUSSION
Our study defines an essential role for LGP2 in promoting immu-
nity through cell-intrinsic regulation of CD8+ T cell survival and
fitness. We found that LGP2 promotes CD8+ T cell survival by
controlling sensitivity to death-receptor signaling. This finding
is highly relevant to the outcome of WNV infection because
CD8+ T cells are the critical immune cell that controls virus repli-
cation and spread within the CNS (Shrestha and Diamond,
2004). In the absence of LGP2, CD8+ T cells did not continue
to expand to WT levels during viral infection, but instead
Figure 6. LGP2 Directly Regulates CD8+ T Cell Survival and Fitness
(A) Schematic of CD8+ T cell adoptive transfer into Rag1/ mice.
(B) Homeostatic proliferation of CD8+ T cells from WT (CD45.1) and Dhx58/ (CD45.2) measured by flow cytometry (left panels, representative flow-cytometry
analysis and gating schematic; right panel, bar graph displaying frequency of divided CD8+ T cells).
(C) NS4b tetramer-specific CD8+ T cells from day 8 postinfection (each connecting line represents cells isolated from the same Rag1/ recipient host; top right
panel, frequency; bottom right panel, relative ratio of NS4b tetramer+CD8+ T cells).
(D) BrdU staining of NS4b tetramer-specific CD8+ T cells from WNV-TX-infected mice on day 8 postinfection (representative flow analysis and bar graph dis-
playing frequency of BrdU+ staining).
(E) Annexin V+ staining of NS4b tetramer-specific CD8+ T cells (representative flow analysis and bar graph displaying frequency of Annexin V+ staining).
(F) Total number of WNV-specific CD8+ T cells secreting IFN-g (left panels), TNF-a (middle panels), or both (right panels). Relative to WT (top panels) and actual
(bottom panels) percentages of CD8+ T cells isolated from the same Rag1/ recipient host.
Graphs show the mean ± SD (n = 3), and data are representative of two or more independent experiments. Asterisks denote p < 0.05.
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Figure 7. LGP2 Controls Sensitivity to CD95-Mediated Apoptosis Signaling
(A–F) Active caspase-8 (A), active caspase-3 and -7 (B), CD120a (C), CD120b (D), CD262 (E), and CD95 (F) expressionmeasured on NS4b tetramer-specific CD8+
T cells from WNV-TX-infected mice on day 8 postinfection (representative flow analysis and bar graph displaying frequency of positive staining).
(G–I) Sensitivity to cell death upon ex vivo treatment with (G) TNF-a, (H) TRAIL, or (I) CD95 ligand.
Splenocytes from adoptively transferred Rag1/ infected mice were isolated and treated on day 8 postinfection. Graphs show the mean ± SD (n = 3), and data
are representative of two independent experiments. Asterisks denote p < 0.05.
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effector function. Furthermore, using an adoptive transfer sys-
tem, we demonstrated that LGP2 acts in a T cell-intrinsic manner
to mediate a prosurvival response. Although we found that LGP2
functions in activated CD8+ T cells independent of canonical
MAVS signaling of RLRs, it remains possible that it may interact244 Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc.with either RIG-I or MDA5 to regulate prosurvival functions of
T cells. Together, these findings reveal a role for LGP2 in CD8+
T cell-mediated immunity to viral infection, and assigns an essen-
tial role for LGP2 in programming antigen-induced survival.
LGP2 has been described as both a positive and negative
regulator of RLR signaling of innate immune defenses against
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et al., 2005; Saito et al., 2007) and has been proposed to
enhance signaling induced by RIG-I or MDA5 in vivo (Satoh
et al., 2010). Our analyses of Dhx58/ primary cells ex vivo vali-
date a positive, albeit cell-specific, role for LGP2 in RLR signaling
of innate defenses, in that LGP2 contributed to sustained RLR
signaling of IFN-b expression. In the absence of LGP2, IFN-b
production from myeloid cells, but not MEFs, was reduced in
response to RNA virus infection, including WNV and DENV2,
two flaviviruses that trigger innate immune defenses through a
combination of RIG-I and MDA5 actions (Fredericksen et al.,
2008; Loo et al., 2008). However, our studies also showed that
LGP2 is not essential for RLR signaling of innate antiviral
defenses. These findings contrast with a previous report that
concluded that LGP2 was essential for RLR signaling of innate
immunity (Satoh et al., 2010). These differences can probably
be attributed to differences in the genetic background of the
mutant mice and gene-targeting strategies between each study.
Importantly, our studies utilized a Dhx58/ mouse that was
generated directly on a pure C57BL/6 background and through
the complete disruption of LGP2 transcription, differing from
prior Dhx58/ mouse lines, which exist in mixed genetic back-
grounds and were created with gene-targeting approaches that
retained the transcriptional start site to render possible messen-
ger RNA expression from the targeted gene (Satoh et al., 2010;
Venkataraman et al., 2007). Although our data overall support
a role for LGP2 as a positive cofactor of innate immune signal-
ing, it remains possible that, under certain conditions, LGP2
also may function to suppress RLR signaling, in that high LGP2
expression was shown to mediate RLR signaling suppression
in several independent studies (Komuro and Horvath, 2006;
Rothenfusser et al., 2005; Saito et al., 2007; Venkataraman
et al., 2007; Yoneyama et al., 2005). Additional studies under
conditions of regulated LGP2 expression in vivo are required to
fully ascertain its role in RLR signaling control.
During virus infection or antigen stimulation, CD8+ T cells
receive multiple signals to undergo rapid proliferation and main-
tain survival. Both cell-intrinsic and -extrinsic apoptotic signaling
pathways are important in regulating peripheral deletion of acti-
vated CD8+ T cells (Michalek and Rathmell, 2010). During the
expansion phase, expression of pro- and antiapoptotic Bcl-2
family members is suppressed, and it remains low through the
cell contraction or death phase, wherein dysregulation of these
processes can lead to premature T cell death (Grayson et al.,
2000). In the absence of LGP2, however, we observed compa-
rable expression of Bcl-2 family members during virus infection,
suggesting that LGP2 does not impart regulation of the intrinsic
apoptosis signaling pathway that is linked with altered ex-
pression of Bcl-2 family proteins. Among programs controlling
effector T cell contraction, the cell-extrinsic apoptosis pathway
is critical for peripheral deletion of activated CD8+ T cells through
death-receptor signaling (Zhang et al., 2005). In particular, CD95
signaling and, to a lesser degree, TNF-a signaling play important
roles in maintaining CD8+ T cell homeostasis and shaping the
peripheral T cell repertoire during infection. In contrast, ‘‘help-
less’’ CD8+ T cells undergo TRAIL-mediated cell death upon re-
activation during a secondary challenge (Janssen et al., 2005).
Under our experimental conditions, we observed enhanced ex-
pression of death receptors in antigen-specific Dhx58/ CD8+T cells, suggesting that LGP2 is important in controlling receptor
expression and, hence, sensitivity to death-receptor-mediated
cell death. Using an ex vivo model, we determined that the
absence of LGP2 led to enhanced sensitivity to CD95-mediated
cell death, but not to TNF-a or TRAIL treatment as compared to
WT treated cells. A lack of TNF-a or TRAIL enhancement of cell
death in Dhx58/ cells does not preclude the possibility that
these death receptors contribute to the enhanced cell death
that is observed in antigen-specificDhx58/CD8+ T cells. Over-
all, our observations imply that LGP2 functions as a molecular
switch to control (by preventing or limiting) death-receptor
signaling during the early stages of T cell activation. We propose
three uniquemechanisms bywhich cell death could be regulated
by LGP2: (1) signaling initiated by protein or RNA interactions of
LGP2 imparts LGP2 actions that regulate prosurvival or proa-
poptotic factor(s); (2) LGP2 signals the expression of prosurvival
or apoptotic gene expression in response to the binding of
specific inducer RNA(s); or (3) LGP2 regulates the synthesis of
prosurvival microRNA species in antigen-stimulated T cells.
Despite comparably low levels of RIG-I or MDA5 expression
upon T cell receptor (TCR) conjugation, it is remains plausible
that LGP2 could also work in conjunction with the other RLRs
to promote CD8+ T cell survival. Due to the embryonic lethality
of RIG-I-deficient mice in a pure C57BL/6 background, we are
unable to evaluate the role of RIG-I in CD8+ T cells at this time
(Kato et al., 2006). However, we and others have evaluated
WNV infection in MDA5-deficient mice and observed normal
proliferation and survival of antigen-specific CD8+ T cells (data
not shown), consistent with a lack of induction of MDA5 expres-
sion upon TCR conjugation. These observations suggest that
LGP2 functions independently of MDA5 to govern CD8+ T cell
survival during virus infection. In support of the third possibility,
recent work has shown that the RNAi pathway protein Dicer,
which regulates microRNA biogenesis, is required for mediating
CD8+ T cell survival, proliferation, and effector functions (Zhang
and Bevan, 2010), and it has recently been demonstrated that
LGP2 can directly interact with components of the RNAi biogen-
esis pathway, including Dicer and Argonaut2 (Li et al., 2011). In
addition, evolutionary studies have suggested that the RLRs
and Dicer have evolved through a common ancestor, suggesting
commonalities in function (Sarkar et al., 2008; Zou et al., 2009).
Thus, it is reasonable to speculate that LGP2 promotes T cell
survival and fitness by regulating gene expression through
governance of microRNA expression. These possibilities are
currently under investigation.
The production of type I IFN and subsequent innate immune
responses is a key linkage point between innate and adaptive
immunity, specifically during T cell function (Havenar-Daughton
et al., 2006; Kolumam et al., 2005; Thompson et al., 2006).
Both TCR stimulation and type I IFN treatment induced RLR
expression in T cells. Though there is little overlap in type I IFN
and TCR signaling pathways, these findings strongly suggest
that each may converge on a common transcriptional element
that regulates the expression of LGP2 and the other RLRs.
In addition to LGP2, the Toll-like receptor adaptor molecule
MyD88 functions in a cell-intrinsic manner to support CD8+ and
CD4+Tcell survival (Gelmanetal., 2004;Quigleyet al., 2009;Rah-
man et al., 2008; Zhao et al., 2009). Although we observed little
requirement for LGP2 in the CD4+ T cell response after WNV orImmunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc. 245
Immunity
LGP2 Regulates CD8+ T Cell Survival and FitnessLCMV infection, it is possible that LGP2 or other RLRs may be
required forCD4+Tcell responseduring infectionbyother viruses
or intracellular pathogens. Consistent with this, MAVS provides
an important signal that controls regulatory T cell expansion dur-
ing viral infection (Suthar et al., 2010). Thus, RLRs andTLRsprob-
ably have a prominent role in coordinating signals that regulate
priming and/or survival of T cell responses during viral infection.
Overall, our results reveal a role for LGP2 in the survival of
activated CD8+ T cells during virus infection. Cell-mediated
responses are essential for protection and clearance of many
virus infections and are critical for successful vaccines against
many pathogens (Pulendran and Ahmed, 2011). Thus, our find-
ings have direct implications for vaccine and adjuvant design
strategies aimed at eliciting sustained antiviral T cell-mediated
responses. Drug designs that engage LGP2 or its downstream
signaling pathways could enhance T cell survival and effector
function for the control of virus infection or, alternatively, promote
cell death for the limitation of immune-mediated pathology.
EXPERIMENTAL PROCEDURES
Cells and Viruses
BHK-21, L929, and L929-ISRE reporter (kind gift from B. Beutler) cells were
cultured in Dulbecco’smodified Eagle’s medium supplemented with 10% fetal
bovine serum (FBS), HEPES, L-glutamine, sodium pyruvate, antibiotic-anti-
mycotic solution, and nonessential amino acids. WNV isolate TX 2002-HC
(WNV-TX) was described previously (Keller et al., 2006) and titered with a stan-
dard plaque assay on BHK-21 cells. Working stocks of WNV-TX were gener-
ated by as previously described (Suthar et al., 2010). LCMV (Armstrong strain)
was plaque purified, grown in BHK-21 cells, and titered as previously
described (Thompson et al., 2006). DENV2was a gift from J. A. Nelson (Oregon
Health and Sciences University). Sendai virus (SeV) strain Cantell was obtained
from the Charles River Laboratory.
Generation of LGP2-Deficient Mice
A conventionalmouse LGP2 gene (encoded byDhx58) deletion procedurewas
performed by inGenious Targeting Laboratory (Stonybrook, NY, USA). The
targeting vector was subcloned from a positively identified C57BL/6 Bacterial
Artifical Chromosome (BAC) clone using a homologous recombination-based
technique. The 13.9kb region that was subcloned contains exons 2–8 of
DHX58. The long homology arm is located on the 50 side of exon 2 and is
7.57 kb long, and the short homology arm extends 1.46 kb 30 to exon 8. A
neomycin positive-selection cassette flanked by loxP sites replaced 4.8 kb of
the gene including exon 2–8 and the ATG start codon in exon 2. A NotI-linear-
ized targeting construct was transfected into iTL IC1 C57BL/6 embryonic stem
cells after electroporation. After selection in G418 antibiotic, surviving clones
were expanded for PCR analysis to identify recombinant embryonic stem cell
clones. The correctly targeted embryonic stem cell clones were microinjected
into C57BL/6J blastocysts. The resulting chimeric mouse was mated with
a WT C57BL/6J mouse to establish germlime transmission. The heterozygous
mice (F1mice)were interbred toobtain homozygousDhx58/mice. Thegeno-
types of the mice were determined by Southern blot analysis (genomic DNA
was cut with PvuII; 543 bp primer probe was generated by the following
primers: WPB1 50-GAAGTCCCTTCTGGGTCCGGGTAC-30; WPB2 50-ATTCT
CCCTAGCCTACTGAGTGAC-30; and PCR (primers: F7, 50–GGAACTTCGCTA
GACTAGTACGCGTG-30; A6, 50-GACAGGACTTGGACATGGACACC-30).
Mouse Experiments
Sti/ mice (C57BL/6 background; referred to in text asMavs/) were gener-
ated in the Gale laboratory in a manner similar to the Dhx58/mice described
in the previous section. The generation and characterization will be discussed
in a future publication. C57BL/6 WT inbred mice, CD45.1 mice, and Rag1/
mice were commercially obtained (Jackson Laboratories, Bar Harbor, ME,
USA). All mice were genotyped and bred in specific pathogen-free conditions
in the animal facility at the University of Washington. Experiments were per-246 Immunity 37, 235–248, August 24, 2012 ª2012 Elsevier Inc.formed in accordance with the University of Washington Institutional Animal
Care and Use Committee guidelines. Age-matched 6- to 12-week-old mice
were inoculated subcutaneously (s.c.) in the left rear footpad with 100 pla-
que-forming units (PFUs) of WNV-TX in a 10 ml inoculum diluted in Hank’s
balanced salt solution supplemented with 1% heat-inactivated FBS. Mice
were monitored daily for morbidity and mortality. A total of 2 3 105 PFU of
LCMV was injected via an intraperitoneal route.
Adoptive Transfers
CD8+ T cells were isolated directly from CD45.1 and Dhx58/ splenocytes
using the negative selection CD8+ T Cell Isolation Kit (Miltenyi Biotec) accord-
ing to the manufacturer’s instructions (greater than 90% purity). Purified CD8+
T cells (2 3106 for each mouse strain) were resuspended in cold PBS and
mixed 1:1 in a total volume of 100 ml. Cells were transferred into sex-matched
Rag1/ mice by intravenous injection through the tail vein. The following day
(24 hr posttransfer), mice were infected with 100 PFUWNV-TX through the s.c.
route in the left rear footpad, andmiceweremonitored daily as described in the
previous section.
Viral Tissue Burden and Quantification
For in vivo studies, infected mice were euthanized, bled, and perfused with
20 ml of PBS. The whole brain, kidney, and spleen were removed, weighed,
and homogenized in 500 ml of PBS containing 1% heat-inactivated FBS, using
a Precellys 24 at 1,500 rpm for 20 seconds (Bertin Technologies, France).
Sample homogenates were titered by plaque assay on BHK cells. For analysis
of the viral load within the DLN, the pDLN was harvested and total RNA was
extracted (using the RNeasy Kit [Qiagen]), DNase treated (Ambion), and
WNV RNA copy number was measured by qRT-PCR as previously described
(Suthar et al., 2010).
Primary Cell Isolation and Infection
Bone-marrow-derived DCs and macrophages were generated as described
previously (Daffis et al., 2008). The DCs or macrophages were infected with
WNV-TX at an multiplicity of infection (moi) of 1. At the indicated time points,
supernatants were collected for evaluating viral titers and IFN-b by ELISA.
Cells were collected in parallel for immunoblot analysis. Cortical neurons
were isolated from 15-day-old embryonic mice and cultured as described
previously (Samuel et al., 2006). On day 6 of the culture, neurons were infected
withWNV-TX at anmoi of 1, supernatants were collected for virus titration, and
cells were collected for RNA analysis by qRT-PCR using primers described
previously(Suthar et al., 2010).
Immunoblot Analysis
Cellswere lysed in radioimmunoprecipitation assay buffer containing a cocktail
of protease and phosphatase inhibitors (Sigma-Aldrich). Protein extracts
(25 mg) were analyzed by immunoblotting as described previously (Suthar
et al., 2010). The following primary antibodies were used to probe blots:
mouse anti-WNV from the Center for Disease Control; rabbit anti-ISG54
and rabbit anti-ISG49, kindly provided by G. Sen; rabbit anti-MDA5 from
Immuno-Biological Laboratories; mouse anti-tubulin from Sigma-Aldrich;
rabbit anti-GAPDH from Santa Cruz Biotechnology; rabbit anti-STAT1 from
Cell Signaling; and rabbit anti-RIG-I, generated as previously described (Loo
et al., 2008). Secondary antibodies (peroxidase-conjugated goat anti-rabbit,
goat anti-mouse, donkey anti-rabbit, and donkey anti-mouse) were from Jack-
son ImmunoResearch.
RNA Extraction and Analysis
For cultured cells, total RNA was extracted using the RNeasy Kit (Qiagen),
DNase treated (Ambion), and evaluated for ISG49, ISG54, and IFN-b RNA
expression by SYBR Green qRT-PCR. Specific primer sets for ISG-49, ISG-
54, and IFN-b have been described previously (Suthar et al., 2010).
Interferon Bioassay and ELISA
IFN-a and -b were measured in sera using a biological assay as previously
described (Suthar et al., 2010). IFN-b in cell culture supernatants was analyzed
using mouse-specific ELISA kits from PBL Biomedical Laboratories according
to themanufacturer’s protocol. One hundred ml frommock-infected andWNV-
TX-infected neuronal supernatant was used to treat L929-ISRE reporter cells,
and luciferase units were measured 6 hr posttreatment.
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WNV-specific immunoglobulin M and G (IgM and IgG) levels were determined
with an ELISA using purified recombinant E protein as previously described
(Shrestha et al., 2006). The neutralization titer of serum antibody was deter-
mined by using a previously described plaque-reduction neutralization assay
(Diamond et al., 2003a). The dilution at which 50% of plaques were neutralized
was determined after nonlinear transformation of the data.
Histological Analysis
Mock-infected or WNV-infected mice were perfused with PBS (4% parafor-
maldehyde, pH 7.3). Brains were embedded in paraffin, and 10 mm sections
were prepared and stained with hematoxylin and eosin (H&E) by the University
of Washington Pathology Histology Laboratory. Sections were analyzed using
a Nikon Eclipse E600 microscope (University of Washington Keck Microscope
Facility).
Flow-Cytometric Analysis
Splenocytes were isolated, washed, and resuspended in complete RPMI 1640
media (containing 10% FBS), L-glutamine, and antibiotic-antimycotic solution
(cRPMI) before in vitro stimulation. Cells were washed twice before flow-
cytometry staining. For isolation of CNS immune cells, mice were euthanized
and perfused extensively with PBS to remove residual intravascular leuko-
cytes. Brains were isolated and minced in RPMI media, triturated, and di-
gested with Liberase (Roche) and type I DNase in serum-free RPMI media at
37C for 45 min. Immune cells were isolated after gradient centrifugation
from a 37:70% Percoll interface and washed twice with staining buffer.
Immune cells were stained with directly conjugated antibodies specific to
CD3, CD8, CD4, CD95, CD127, KLRG1, CD44, and CD262 (all reagents
from eBioscience); and CD120a and CD120b (from BioLegend). WNV-specific
CD8+ T cells were identified using a tetramer derived from an NS4b peptide
restricted to the MHC class I Db allele (produced at the immune monitoring
core facility at the Fred Hutchinson Cancer Research Center, Seattle) directly
conjugated to either phycoerythrin (PE) or allophycocyanin (APC). Annexin V+
staining was performed according to the manufacturer’s instructions (BD
Biosciences). Pacific Blue-conjugated Annexin V+ (BioLegend) or fluorescein
isothiocyanite (FITC)-conjugated Annexin V+ (BD Biosciences) was used for
staining. Intracellular FoxP3 staining to identify regulatory T cells was per-
formed as previously described (Lund et al., 2008; Suthar et al., 2010). Intracel-
lular IFN-g and TNF-a staining was performed on splenocytes as previous
described (Suthar et al., 2010). In brief, lymphocytes were stimulated with
1 mg/ml of the WNV NS4b peptide (SSVWNATTAI) or LCMV-GP33 (GP33–41)
for 4 hr at 37C. Cells were washed and stained for cell surface markers
followed by permeabilization-fixation using the Cytofix-Cytoperm Kit (BD
Pharmingen) and stained with a Pacific Blue-conjugated IFN-g and a FITC-
conjugated TNF-a antibody (eBioscience) at 4C for 30 min, washed, and
analyzed by flow cytometry. Caspase activity wasmeasured using the Vybrant
FAM Caspase-3 and -7 or Caspase-8 Assay Kit (Invitrogen), according to the
manufacturer’s instructions. For detection of intracellular Bcl-2, cells were
fixed and treated with the FoxP3 intracellular staining kit (eBioscience) fol-
lowed by staining with an APC-conjugated Bcl-2 antibody (BioLegend). For
detection of Bim and Bcl-xL, cells were fixed for 10 min with 4% paraformal-
dehyde at room temperature, permeabilized with 0.1% saponin for 30 min
on ice, and stained with Bim (Cell Signaling), Bcl-xL (Clone 54H6; Cell
Signaling), and isotype control (Rabbit IgG mAb clone DA1E) antibody for
30 min on ice. Alexa Fluor 488-conjugated (Cell Signaling) secondary antibody
was used at a dilution of 1:1,000, and cells were analyzed by flow cytometry.
For measurement of CD8+ T cell proliferation in vivo, mice were injected with
1 mg of BrdU for 6 hr via the intraperitoneal route, and splenocytes were
stained with CD8, PE-conjugated NS4b tetramer, and APC-conjugated
BrdU, according to the manufacturer’s instructions. Flow cytometry was per-
formed on aBD LSRII machine using BD FACSDiva software. Cell analysis was
performed on FlowJo (v8.7.2) software.
Analysis of TNF-a-, TRAIL-, and CD95L-Mediated Cell Death
For TNF-a and TRAIL treatments, splenocytes from recipientRag1/ infected
mice were resuspended in cRPMI and cultured at 37C for 6 hr with either
2 ng/ml TNF-a or 20 ng/ml SuperKillerTRAIL (Enzo Life Sciences). For
CD95L treatment, splenocytes were cultured at 37C for 3 hr with 250 ng/mlFLAG-tagged recombinant CD95L (Alexis Biochemicals) crosslinked by
4 mg/ml M2 monoclonal anti-FLAG antibody (Sigma-Aldrich). Cells were
stained and analyzed for cell death (Annexin V+) by flow cytometry.
Ex Vivo TCR Stimulation
CD8+ T cells were isolated directly from WT and Dhx58/ splenocytes using
the negative selection CD8+ T Cell Isolation Kit (Miltenyi Biotec) according to
the manufacturer’s instructions. For ex vivo TCR stimulation, 96-well plates
were precoated overnight with 1 mg/ml anti-CD3 (BioLegend) and 5 mg/ml
anti-CD28 (BioLegend). Isolated CD8+ T cells were plated (6 3 105 cells per
well) in 200 ml cRPMI media supplemented with 500 IU/ml of murine IL-2.
Statistical Analysis
For in vitro studies and immune cell analysis, an unpaired Student’s t test was
used to determine statistical differences. For in vivo viral-burden analysis,
Mann-Whitney analysis was used to determine statistical differences. Ka-
plan-Meier survival curves were analyzed by the log-rank test. A p value %
0.05 was considered statistically significant. All data were analyzed using
Prism software (GraphPad Prism5).
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